Stallergenes Greer
Stallergenes Greer Ltd is a biopharmaceutical company focused on the diagnosis and treatment of respiratory allergies through the development and commercialization of allergy immunotherapy products and services. The company offers a diverse range of products, including sublingual therapies such as Staloral liquid drops and Oralair dissolving tablets, as well as subcutaneous allergen extracts like Phostal and Alustal. Stallergenes Greer also provides bulk extracts, sterile vials, and various components for enzyme-linked immunosorbent assays, alongside prescription services for veterinary dermatologists and reference laboratories. With over 1,400 employees and operations in 75 countries, the company aims to enable individuals with allergies to lead normal lives. Stallergenes Greer was incorporated in 2013 and is headquartered in London, United Kingdom.
Spot something off? Help us improve by flagging any incorrect or outdated information. Just email us at
support@teaserclub.com. Your feedback is most welcome.